Residual macrovascular risk in 2013: what have we learned?

Cardiovascular disease poses a major challenge for the 21st century, exacerbated by the pandemics of obesity, metabolic syndrome and type 2 diabetes. While best standards of care, including high-dose statins, can ameliorate the risk of vascular complications, patients remain at high risk of cardiova...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Fruchart, Jean-Charles, Davignon, Jean, Hermans, Michel P, Al-Rubeaan, Khalid, Amarenco, Pierre, Assmann, Gerd, Barter, Philip, Betteridge, John, Bruckert, Eric, Cuevas, Ada, Farnier, Michel, Ferrannini, Ele, Fioretto, Paola, Genest, Jacques, Ginsberg, Henry N, Gotto, Antonio M, Hu, Dayi, Kadowaki, Takashi, Kodama, Tatsuhiko, Krempf, Michel, Matsuzawa, Yuji, Núñez-Cortés, Jesús Millán, Monfil, Carlos Calvo, Ogawa, Hisao, Plutzky, Jorge, Rader, Daniel J, Sadikot, Shaukat, Santos, Raul D, Shlyakhto, Evgeny, Sritara, Piyamitr, Sy, Rody, Tall, Alan, Tan, Chee Eng, Tokgözoğlu, Lale, Toth, Peter P, Valensi, Paul, Wanner, Christoph, Zambon, Alberto, Zhu, Junren, Zimmet, Paul
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922777/
https://ncbi.nlm.nih.gov/pubmed/24460800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-13-26
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы